The announcement was in December 2023 which is why I said they discussed the costing for 18 months. The sponsor approached IMU to do this Ph2 clinical trial, IMU has been very busy with their other more important IP.
Ann: 1st Australian site activated PD1-Vaxx Neo-POLEM Ph II trial, page-72
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $97.44K | 6.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 79 | 15291052 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 8512549 | 35 |
View Market Depth
| Last trade - 15.51pm 16/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |